Company Mabvax Therapeutics Holdings Inc Other OTC
Equities
US55414P1084
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2020 | MabVax Therapeutics Holdings, Inc. Went Out of Business | CI |
2020 | Second Amended Liquidation Plan & Disclosure Statment Approved for MabVax Therapeutics Holdings, Inc. | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 72 | - | |
Chief Tech/Sci/R&D Officer | 81 | 08/14/08 | |
Paul W. Maffuid
CTO | Chief Tech/Sci/R&D Officer | 68 | 08/14/08 |
Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | 81 | 08/14/08 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 33,333 | 0 | 0 | 92.02 % |
Stock B | 0 | 44,104 | 0 | 0 | |
Stock C | 1 | 9,429,582 | 8,677,104 ( 92.02 %) | 0 |
Company contact information
MabVax Therapeutics Holdings, Inc.
559 Evans Mountain Road
72031, Clinton
+858-259-9405
Sector
1st Jan change | Capi. | |
---|---|---|
+18.77% | 125B | |
+14.05% | 108B | |
-7.16% | 23.64B | |
+2.07% | 22.39B | |
-10.79% | 17.78B | |
-41.74% | 16.43B | |
-13.47% | 16.34B | |
+2.23% | 13.56B | |
+27.13% | 11.59B |
- Stock Market
- Equities
- MBVXQ Stock
- Stock
- Company Mabvax Therapeutics Holdings Inc